Stay ahead of regulatory changes with this targeted course on the FDA’s classification of cardiovascular machine learning-based notification software. Learn what it means for your device to be classified as class II with special controls, including detailed compliance steps, premarket notification (510(k)) submission, clinical validation, software requirements, labeling standards, and risk mitigation. Equip your organization to streamline market entry, safeguard patient safety, and minimize legal or regulatory setbacks under the latest FDA rule.
In this course you will learn the following:
* Understand the FDA’s rationale for classifying cardiovascular machine learning-based notification software as class II.
* Identify the key special controls and general controls required for compliance.
* Outline the steps necessary to meet premarket notification (510(k)) requirements.
* Recognize the risks associated with these devices and the required mitigation measures.
* Understand the legal and regulatory consequences of non-compliance.
